title: Hypertrichosis of the eyelashes caused by bimatoprost.
abstract: The phenyl-substituted analog of prostaglandin F 2alpha , latanoprost (Xalatan; Pfizer, Inc, New York, NY) is an intraocular pressure (IOP)-lowering drug for use in patients with glaucoma and ocular hypertension. Latanoprost has been shown to stimulate eyelash hypertrichosis and has recently been proposed as a possible treatment for alopecia areata involving the eyelashes. We report a case of hypertrichosis of the eyelashes caused by the prostamide bimatoprost (Lumigan; Allergan, Inc, Irvine, Calif), a new IOP-lowering drug.
authors.affiliation: Department of Dermatology, University of Bologna, Italy. tosti@med.unibo.it
authors.forename: Antonella
authors.initials: A
authors.lastname: Tosti
authors.forename: Massimiliano
authors.initials: M
authors.lastname: Pazzaglia
authors.forename: Stylianos
authors.initials: S
authors.lastname: Voudouris
authors.forename: Giovanni
authors.initials: G
authors.lastname: Tosti
mesh_terms: D000368:Aged; D000577:Amides; D000959:Antihypertensive Agents / Q000009:adverse effects*; D000069580:Bimatoprost; D003008:Cloprostenol / Q000031:analogs & derivatives; D005140:Eyelashes; D005260:Female; D005902:Glaucoma, Open-Angle / Q000188:drug therapy; D006801:Humans; D006983:Hypertrichosis / Q000139:chemically induced*; D008055:Lipids / Q000009:adverse effects*
chemical_list: D000577:Amides; D000959:Antihypertensive Agents; D008055:Lipids; D003008:Cloprostenol; D000069580:Bimatoprost